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Coenzyme Q10 (CoQ10, ubiquinone), a potent antioxidative dietarysupplement, was produced by submerged fermentation using
Agrobacterium tumefaciens instead of chemical synthesis or solvent extraction. Agrobacterium tumefaciens 1.2554 was subjected
to mutagenesis using a series of treatments including high hydrostatic pressure (HHP) treatment, UV irradiation, and diethyl
sulfate (DES) treatment to obtain mutant strains showing higher CoQ10 production than wild-type strains. A mutant strain PK38
with four genetic markers was isolated: the speciﬁc CoQ10 content of the mutant strain increased by 52.83% compared with the
original strain. Eﬀects of carbon and nitrogen sources on CoQ10 production with PK38 were studied. Sucrose at concentration
of 30g/l was tested as the best carbon source, and yeast extract at concentration of 30g/l supplemented with 10g/l of ammonium
sulfate was identiﬁed to be the most favorable for CoQ10 production using PK38. Fed-batch culture strategy was then used for
increasing production of CoQ10 in 5-l fermentor. Using the exponential feeding fed-batch culture of sucrose, cell growth and
CoQ10 formation were signiﬁcantly improved. With this strategy, the ﬁnal cell biomass, CoQ10 production, and speciﬁc CoQ10
production increased by 126.11, 173.12, and 22.76%, respectively, compared to those of batch culture.
1.Introduction
Coenzyme Q10 (CoQ10), also known as ubiquinone or
ubiquinone-10, occurs widely in animals, plants, and the
cells of microorganisms. It plays a crucial role in generation
of cellular energy and in free radical scavenging in the
human body [1].Accordingly,ithasbeenusedintherapeutic
applications for several diseases such as heart disease [2],
breast cancer [3], and Alzheimer’s and Parkinson’s diseases
[4]. Moreover, CoQ10 has been used as a food supplement
and cosmetic ingredient because of its various physiological
functions. Extensive attempts have been made to increase
CoQ10 production to meet growing demands for this
product. To date, production of CoQ10 is produced by one
of three methods: extraction from biological tissues [5],
chemical synthesis [6], and microbial fermentation [7]. In
the wake of recent environmental awareness, the ﬁrst two
methods became least desirable because of the inherent
uses of solvents and chemicals in the process. Microbial
fermentation, conversely, oﬀers an environmentally benign
option based on the enzymatic catalysis at the cellular level
for CoQ10 assembly. Also, this approach is attractive to
the industry because the process is easy to control and has
a relatively low production cost [8, 9]. Among all strains
investigated so far, A. tumefaciens has been shown to be an
excellent producer of CoQ10 [7, 10–13]. However, the yield
of CoQ10 in liquid cultivation using the wild-type strain of
A. tumefaciens remains limited because of its low speciﬁc
CoQ10 content.
To increase the speciﬁc CoQ10 content of A. tumefa-
ciens, further strain development by physical and chemical
mutagenesishasbeenusedtoobtainhigh-CoQ10-producing
mutants. Well-known mutagens such as ultraviolet radiation
and diethyl sulfate (DES) have been tested. However, the
chemicalsusedforthesemutagenesisproceduresareharmful
to human health. It is desirable to ﬁnd new mutagenic
treatments to increase CoQ10 yield.2 Journal of Biomedicine and Biotechnology
In recent years, there were reports about high hydrostatic
pressure (HHP) treatment that inﬂuenced the structure
of genes and proteins in microorganisms [14–16]. There
were also reports that HHP treatment in laboratory could
cause beneﬁcial mutagenesis to E. coli [17, 18], R. glutinis
[19, 20], and G. xylinus [21]. Compared with traditional
physicalandchemicalmutagenesismethods,HHPtreatment
as a mutagen could oﬀer some advantages such as easier
handling, savings in time and money, and negligible eﬀects
to the environment [19, 20]. However, little is known related
to the eﬀectiveness of HHP treatment on improving the
production of CoQ10 in microorganisms.
Carbon and nitrogen sources signiﬁcantly aﬀected cell
growth and CoQ10 production [12]. Aside from the opti-
mization of carbon and nitrogen sources, the use of fed-
batch culture by controlling the nutrient feeding is one of
the most popular methods to achieve high cell density of E.
coli [22–24] and enhance the production of CoQ10 [11, 12].
Exponential feeding is a simple method that was widely
employed for E. coli cultivation [23]. So far, there seem to be
no published reports related to the CoQ10 production under
exponential feeding fed-batch control.
In this study, HHP treatment was investigated as a new
mutagenic treatment to increase the speciﬁc CoQ10 content
of A. tumefaciens. A mutant strain PK38 was isolated using
selection markers and the optimal carbon and nitrogen
sources for CoQ10 production with PK38 were selected. A
new exponential feeding strategy was proposed for improv-
ing CoQ10 production using PK38.
2.MaterialsandMethods
2.1.MicroorganismandCultureMedium. Thepar entalstrain
A. tumefaciens 1.2554 was purchased from China General
Microbiological Culture Collection Center (CGMCC, Bei-
jing, China). This strain was inoculated on mannitol agar
slants, incubated for 2 days at 28◦C, and then stored at 4◦C.
All media were sterilized by autoclaving at 121◦Cf o r
20min and were adjusted to pH 7.2 before sterilization.
The complete medium contained 5g/L glucose, 3g/L beef
extract, 3g/L yeast extract, 10g/L peptone, and 0.2g/L
MgSO4·7H2O. The selective medium was made by adding
a certain amount of one of the following four substances:
sodium azide, ethionine, daunomycin, or vitamin K3.T h e
seed medium consisted of 10g/L glucose, 5g/L peptone,
5g/L yeast extract, and 5g/L NaCl. The basal fermentation
medium contained 20g/L glucose, 10g/L peptone, 10g/L
yeast extract, 0.5g/L K2HPO4,0 . 5g / LK H 2PO4 0.5g/L, and
0.5g/L MgSO4·7H2O.
2.2. Preparation of Cell Suspensions. One loop of bacterial
cells grown overnight on a mannitol agar slant was inoc-
ulated to 250mL Erlenmeyer ﬂask containing 50mL of a
seed medium and incubated on a rotary shaker (200rpm)
at 28◦C for 24h. After the culture entered the log phase
(about 18–24h in this study), 20mL culture broth was
centrifuged under 4◦C at 10,000rpm (21,000×g) for 10min
(PM180R, ALC International, Milan, Italy), washed twice
with sterile physiological saline, and suspended in sterile
0.1M potassium phosphate buﬀer of pH 7.2 (cells density
106–107 cell/mL) for HHP treatment.
2.3. HHP Mutation. The cell suspension in potassium phos-
phate buﬀer was transferred aseptically into sterile polyethy-
lene pouches and heat-sealed following the expulsion of air.
The prepared pouches were placed into the HHP equipment,
containing a 2l working pressure chamber (UHPF-750MP,
Baotou Kefa New Type Hi-Tech Food Machine Limited
Company, Baotou, China). HHP treatments at constant
pressures from 100 to 400MPa with holding time (10 to
30min) were carried out at room temperature (about 25◦C)
using castor oil as the pressure medium. Control samples
weremaintainedatatmosphericpressurewithintheconstant
temperature housing during the experiment.
To assess loss of viability caused by the HHP treatment,
untreated and treated cell suspensions were serially diluted
in PBS and plated on the basal agar plates. Agar plates were
incubated at 28◦C for 2 days for colony counting. Inacti-
vation was expressed as a logarithmic viability reduction
log(N0/N), with N0 and N representing the colony counts
before and after treatment, respectively [25].
2.4. UV+DES Mutation. The cell suspension was spread
onto a presterilized plate (9cm diameter), and a UV lamp
(254nm, 30W) was used for the mutation by irradiating
cells at a distance of 30cm from the plate for 60s. After UV
radiation treatment, the cell suspension was treated with 1%
(v/v) DES for 20min. The results show that the frequency of
positive mutant generation is 12%.
2.5. Screening for High-CoQ10-Producing Mutant. After each
treatment, cell suspensions were spread on the selective
medium and incubated at 28◦C for 48h. The selec-
tive medium contained L-ethionine (500mg/L), dauno-
mycin (20mg/L), vitamin K3 (160mg/L), or sodium azide
(20mg/L). All these chemicals were purchased from Ding
Guo Biological Technology Co., LTD (Beijing, China). The
fast-growing, large, and single colony was transferred onto
the selective medium plate and then incubated for 48h at
28◦C. The slant was preserved at 4◦C.
For screening, each mutant was taken and used in
fermentation, and the content of CoQ10 from each mutant
was determined.
2.6. Fermentation. The seed culture was transferred into a
stirred tank fermentor (BioFlo 110, New Brunswick, NJ,
USA) with a working volume of 2l production medium. The
temperature, agitation speed, and air ﬂow rate during the
culture were 28◦C, 300rpm, and 0.6 l/min, respectively. The
p Hw a sc o n t r o l l e da t7 .2 ± 0.1 by addition of 3M NaOH or
2M HCl.
2.7. Analytical Methods. The cell mass concentration was
determined using a calibration curve constructed by optical
density at 620nm and dry cell weight (DCW). The optical
density at 620nm was measured with a spectrophotometerJournal of Biomedicine and Biotechnology 3
Table 1: HHP treatments on mutation of A. tumefaciens.
Mutation No. of strains (N)P o s i t i v e m u t a n t ( r %) Speciﬁc CoQ10 content (mg/g DCW) Improvement (r %)
400Mpa/10min 56 5 1.645 8.4
250Mpa/20min 80 10 1.690 11.3
200Mpa/30min 78 16 1.784 17.5
(UV-2500, Shimadzu, Tokyo, Japan). The DCW was deter-
mined after the culture broth was centrifuged at 10,000rpm
(21,000×g) for 10min under 4◦C using an ultracentrifuge.
Cell lysis and CoQ10 extraction conducted in this study were
similar to that described by Tian et al. [26]. The extracted
CoQ10 was dissolved in ethanol and applied to a high-
performance liquid chromatography (HPLC) system (LC-
2010A, Shimadzu, Tokyo, Japan) with a Hypersil ODS C18
(5μm, 4.6mm × 250mm, Germany) coupled with a UV
detector (Waters 486). The column was eluted with ethanol
and methanol (9:1, v/v) at a ﬂow rate of 1.0mL/min, and a
chromatogram was obtained by monitoring the absorbance
at 275nm. With an authentic CoQ10 standard (Sigma
Co., Shanghai, China), CoQ10 was identiﬁed according to
retention time and quantiﬁed by using a calibration curve.
The residual sugar was quantiﬁed by Fehiling’s reaction.
2.8. Statistical Analysis. All analyses were performed in
triplicate. The experimental results obtained were expressed
as means ± SD. Statistical analysis was performed using the
SPSS package (version 11.5, SPSS Inc., Chicago, IL). Data
were analyzed by analysis of variance (P<0.05), and the
means were separated by Duncan’s multiple range test.
3. Results andDiscussion
3.1. Eﬀect of HHP Treatment on Lethal Rate and Mutation
of A. tumefaciens. To determine the optimum mutagenic
conditions by HHP treatment, cell suspensions of A. tumefa-
ciens were subjected to diﬀerent HHP treatments combining
pressure with holding time at 25◦C. Figure 1 shows the
death curve of A. tumefaciens with HHP treatment. The
data revealed that HHP treatment had a signiﬁcant eﬀect
on A. tumefaciens, a Gram-negative bacterium. In general,
Gram-negative bacteria are less resistant than the Gram-
positive bacteria to HHP treatments [25]. In this study,
the cell viability during HHP treatment decreased with the
increase of processing pressure and holding time. Based on
the curve (Figure 1), deactivation of cells occurred between
4.0 and 4.5 log units at 200MPa for 30min, 250MPa for
20min, or 400MPa for 10min. Under these three levels,
the mortality of A. tumefaciens was close to 100% (data
not shown). Therefore, these three levels were chosen for
subsequent mutagenesis [21].
Table 1 shows the eﬀect of HHP treatments on mutation
of A. tumefaciens. It is evident that the HHP treatment, at
200MPa for 30min, is better than the other two treatments:
250MPa for 20min and 400MPa for 10min. Positive
mutations accounted for 16% of these mutants, and 12
strains had a speciﬁc CoQ10 content higher than that from
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Figure 1: Death curve of A. tumefaciens caused by HHP treatment.
Process temperature 25◦C. logRF = log(N0/N). Data are shown as
mean ± SD (n = 3).
the wild-type strain. Among those 12 strains, maximum
speciﬁc CoQ10 content was achieved from the mutant PN07
with an approximate 17.5% increase compared with the
wild-type strain. So the HHP treatment at 200MPa for
30min was selected as the optimal condition for inducing
mutation.
CoQ10 biosynthesis is typically composed of three parts:
synthesis of a quinonoid ring, synthesis of decaprenyl
diphosphate, and quinonoid ring modiﬁcation [9]. The
formation of each part is catalyzed by several enzymes. For
example, decaprenyl diphosphate synthase (DPPS) can cat-
alyze the synthesis of decaprenyl diphosphate, which appears
to be a rate-limiting step and critical in CoQ10 production
[9, 27]. The present study found that HHP treatment can
have beneﬁcial mutagenic eﬀects on A. tumefaciens for
CoQ10production,whichagreeswiththeﬁndingofWuetal.
[21] who found that the bacterial cellulose mutant M438 was
obtained after HHP treatment at 250MPa for 15min. Wang
et al. [19, 20] obtained the barotolerant mutant PR68 after
ﬁverepeatedcyclesofHHPtreatmentat300MPafor12min.
They found that the DNA segments of mutant PR68 were
diﬀerent from the original strain. Lauro et al. [28]r e p o r t e d
that pressure triggered a stress response which activated
distinct chaperones and DNA repair proteins. So the change
of speciﬁc CoQ10 content of A. tumefaciens might occur at
the gene level, and HHP treatment might have eﬀects on the4 Journal of Biomedicine and Biotechnology
1.2554 (1.518)
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HHP UV + DES
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UV + DES UV + DES
MT18 (Tyr−, 2.015)
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PN07 (NaN3
r, 1.781)
(VK3
r, 2.242) (Daur, 2.214) (VK3
r, 2.32)
ME41 (Ethr, 2.206)
MN22 (NaN3
r, 1.613)
Figure 2: Genealogy of mutant strains derived from AT 1.2554.
Mutation markers: NaN3
r, sodium azide (NaN3) resistance; Tyr−,
tyrosine auxotroph; Eth
r, ethionine resistance; Dau
r daunomycin
resistance; VK3
r, vitamin K3 resistance. All the mutants were
induced by HHP or UV + DES treatment. The speciﬁc CoQ10
content (mg/g dry cell weight) was obtained in ﬂask tests.
three enzymatic steps of CoQ10 biosynthesis. Study of these
eﬀects should be carried out in future research.
3.2. Screening A. tumefaciens. Random mutagenesis is an
easy tool to use in achieving genetic and functional
modiﬁcations of an organism. Using progressive stepwise
mutagenesis-selection protocols and various mutagens with
diﬀering modes of action has been proven eﬀective in
increasing product yield [29]. To obtain a high-CoQ10-
producingstrainfromthewildtype,mutagenesiswascarried
out by the HHP treatment (200MPa, 30min) and UV+DES
mutation. After each mutagenic treatment, the mutant strain
was selected and assessed in shake ﬂask cultures. The
most promising strain was subjected to the next mutagenic
treatment.
According to the general pathway of CoQ10 synthesis,
two means of additional CoQ10 production are possible: the
mutant could overcome growth inhibition during CoQ10
biosynthesis or its related metabolisms might overproduce
CoQ10 [9]. These chemicals included L-ethionine (an
analogue of L-methionine, which is a precursor for the
methoxy moiety of CoQ10), daunomycin, and vitamin K3
(structural analogs of CoQ10). CoQ10 is an electron carrier
in the respiration chain with antioxidant activity [30]. An
electron ﬂux inhibitor, such as sodium azide, can be used
for screening the mutant, which can be resistant to this
inhibitor because of high intracellular CoQ10 [9]. Moreover,
tyrosine is located at a ﬁnal branch point in the pathway of
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Figure 3: Eﬀect of various carbon sources on the cell growth and
CoQ10 production. Cells were cultivated in the test tube at 28◦Cf o r
72h. The carbon sources included glucose (1), fructose (2), lactose
(3),maltose(4),sucrose(5),andxylose(6).Dataareshownasmean
± SD (n = 3). Means with the same letter are not signiﬁcantly
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Figure 4: Eﬀect of various nitrogen sources on the cell growth and
CoQ10 production. Cells were cultivated in the test tube at 28◦Cf o r
72h. The nitrogen sources included yeast extract (1), peptone (2),
tryptone(3),soytone(4),ammoniumsulfate(5),andCSP(6).Data
are shown as mean ± SD (n = 3). Means with the same letter are
not signiﬁcantly diﬀerent (P<0.05).
CoQ10biosynthesis.Soatyrosineauxotrophicmutantmight
enhance CoQ10 production.
As Figure 2 shows, the mutant strains isolated with
r e s p e c t i v ec h e m i c a l sa te a c hm u t a t i o ns t e pw e r et e s t e df o r
their CoQ10 production by ﬂask culturing, and the best
strain was used as the parent for successive mutations.
Figure 2 also shows the methods and the maximal speciﬁc
CoQ10 content for such mutants. Among those chemicals
used for selecting a high producer, daunomycin had no
signiﬁcant eﬀect on the CoQ10 content. Finally, the strain
with the highest speciﬁc CoQ10 content, named PK38, wasJournal of Biomedicine and Biotechnology 5
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Figure 5: Proﬁles of DCW and CoQ10 production in batch (a), fed-batch (b), and exponential fed-batch (c) culture with PK38 in the 5-L
fermentor at 28◦C; residual sugar (RS, ﬁlled square), CoQ10 (ﬁlled circle), DCW (ﬁlled inverted triangle).
Table 2: The experiment testing genetic stability and speciﬁc
CoQ10 content of PK38.
Generations 2468 1 0
Genetic markersa +++++
Speciﬁc CoQ10 content
(mg/g)
2.321 2.320 2.318 2.319 2.318
aGenetic markers included NaN3
r,T y r
−,E t h r, and Vk3
r.
obtained, containing about 52.83% higher speciﬁc CoQ10
content when compared with the original strain.
3.3. Stability of PK38 for CoQ10 Production. The mutant
PK38 was selected, and its stability of producing speciﬁc
CoQ10 content was investigated (Table 2). There was little
ﬂuctuationinspeciﬁcCoQ10contentamong10generations.
Also, the genetic markers were stable. This illustrated PK38
strain has a good genetic stability and has the potential to be
used for CoQ10 production.
3.4. Optimization of Carbon and Nitrogen Sources. To deter-
mine the optimal carbon and nitrogen source for CoQ10
production, cultures were prepared in 250mL ﬂasks contain-
ing 100mL of fermentation medium with various carbon
and nitrogen sources and incubated for 72h on a rotary
shaker (at 180rpm) at 28◦C.
Figure 3 shows the eﬀect of diﬀerent carbon sources on
PK38 growth and CoQ10 production. Among the various
carbon sources (glucose, fructose, lactose, maltose, sucrose,
and xylose), sucrose proved to be the best carbon source
for the growth of PK38 with biomass reaching 5.28g/L
after 72 hours of cultivation. Also, CoQ10 production was
the highest when sucrose was used as a carbon source,
reaching 12.27mg/L. These results are in agreement with
the work conducted by Ha et al. [12]. To evaluate the eﬀect
of the initial concentrations of sucrose on PK38 growth
and CoQ10 production, diﬀerent concentrations of sucrose
(10, 20, 30, 40, and 50g/L) were used. As Table 3 shows,
CoQ10 production was highest at 30g/L of sucrose, reaching
14.88mg/L. So sucrose, at a concentration of 30g/L, was
selected as carbon source for CoQ10 production with PK38.
Figure 4 shows the eﬀects of diﬀerent nitrogen sources
on biomass and CoQ10. The results demonstrate that crop
steep powder (CSP) was more desirable than other nitrogen
sources. The highest CoQ10 production (17.65mg/L) was
obtained with 20g/L of CSP, with the highest biomass at
7.16g/L. CSP comprises the water soluble components of
the crop, the composition of which is primarily amino acids,
peptides, carbohydrates, and salts. CSPs are rich in nitrogen,6 Journal of Biomedicine and Biotechnology
Table 3: Eﬀect of sucrose on DCW and CoQ10 production by PK38 with batch culture.
Sucrose (g/L) DCW (g/L) CoQ10 concentration (mg/L) Speciﬁc CoQ10 content (mg/g DCW)
10 4.11 + 0.065d 9.55 + 0.196d 2.325 + 0.037a
20 5.28 + 0.157b 12.27 + 0.110b 2.322 + 0.029a
30 6.40 + 0.161a 14.88 + 0.172a 2.326 + 0.069a
40 4.90 + 0.181c 11.40 + 0.284c 2.324 + 0.101a
50 4.12 + 0.148d 9.56 + 0.056d 2.320 + 0.019a
Data are shown as mean ± SD (n = 3). Means with the same letter are not signiﬁcantly diﬀerent as indicated by Duncan’s multiple range test (P < 0.05).
vitamins, and other growth stimulating compounds. There-
fore, CSP was used as an ingredient in media for cultivation
of microorganisms. Diﬀerent concentrations of CSP (10, 20,
30, 40, and 50g/L) were used to evaluate the eﬀect of the
initial concentrations of CSP on PK38 growth and CoQ10
production. As Table 4 shows, CoQ10 production was the
highest with 30g/L of sucrose, reaching 18.92mg/L. Ammo-
niummayalsohaveeﬀectsonCoQ10synthesis.Knowlesand
Redfearn [31] found that the cells of Azotobacter vinelandii
grownonammoniummediumproducedcomparativelyhigh
concentrations of CoQ10. Obviously, the complex nitrogen
source (CSP + ammonium sulfate) was more desirable than
singlenitrogensources(Table5).CoQ10productionreached
20.62mg/L with30g/L CSP and 10g/L ammonium sulfate in
the production medium.
3.5. Fed-Batch CoQ10 Fermentation in 5-l Fermentor. Fig-
ure 5(a) shows the batch proﬁle of DCW and CoQ10
production with the mutant PK38 in the 5-l fermentor
under the optimal carbon and nitrogen sources. During the
batch fermentation of PK38, cell aggregation was observed
after incubation, and after 42h, the cells were not grown
further. The ﬁnal yield of CoQ10 reached 43.94mg/L,
which was signiﬁcantly higher than that reached in the
ﬂask culture (20.62mg/L), indicating that the low constant
agitation(300rpm)providedinthe5-lfermentormighthave
enhanced cell-substrate contact [32], leading to the increase
in CoQ10 productivity. The ﬁnal biomass of PK reached
13.75g/L,whichwasalmost2timesthatobtainedintheﬂask
culture (7.86g/mL). This indicates that the speciﬁc CoQ10
content was 3.196mg/g-DCW, which is much higher than
that achieved in the ﬂask culture (2.624mg/g-DCW).
As shown in the batch fermentation, CoQ10 production
is mainly dependent on cell growth. A fed-batch fermenta-
tion of PK38 was carried out to get a high cell density and
to increase more CoQ10 accumulation. When the residual
sugar concentration of the broth dropped to about 17.5g/L,
100 l of a sucrose solution (30%) was fed to the 5 l fermentor.
As Figure 5(b) shows, sucrose feed was performed at 18, 30,
and 40h, respectively. The feed strategy was designed so the
residual sugar was kept at a concentration of 17–28g/L. The
feeding proﬁle was found to be optimum, by maintaining
a higher concentration of the residual sugar in the broth
during the log phase of PK38. As a result, the cell density
increased to 25.99g/L, which was almost twice the amount
obtained in the batch fermentation. Speciﬁcally, the ﬁnal
CoQ10productionreached92.87mg/Lin96hofincubation,
Table 4: Eﬀect of CSP on DCW and CoQ10 production by PK38
with batch culture.
CSP
(g/L) DCW (g/L)
CoQ10
production
(mg/L)
Speciﬁc CoQ10
content
(mg/g-DCW)
10 6.67 + 0.061c 15.67 + 0.080d 2.351 + 0.016c
20 7.16 + 0.116b 17.65 + 0.120b 2.466 + 0.017b
30 7.46 + 0.095a 18.92 + 0.146a 2.536 + 0.047a
40 7.07 + 0.080b 16.60 + 0.062c 2.347 + 0.035c
50 7.62 + 0.038a 16.81 + 0.182c 2.207 + 0.022d
Data are shown as mean ± SD (n = 3). Means with the same letter are
not signiﬁcantly diﬀerent as indicated by Duncan’s multiple range test (P <
0.05).
which was signiﬁcantly higher than the batch operation.
This demonstrates that the speciﬁc CoQ10 content achieved
3.575mg/g-DCW, which is much higher than that achieved
in the batch fermentation.
In general, microorganisms will grow exponentially
under the optimal condition. If the feed rate of the substrate
is increased in proportion to the exponential growth rate,
it is possible to maintain a high rate of cell growth for
al o n gt i m e[ 33]. Also, exponential feeding can limit the
negative eﬀect on the cell growth exerted by the sudden
increase of sucrose. Figure 5(c) shows the proﬁles of DCW
and CoQ10 production with the mutant PK38 in the 5-l
fermentor under the exponential feeding fed-batch control.
The sucrose feed started from 12h when the residual sugar
concentration in the broth dropped to 21g/L. The sucrose
solution (30%) ﬂow rate proﬁle was established in the equa-
tion described by Mart´ ınez et al. [34]. CoQ10 production
increased quickly after 18h of incubation, and the ﬁnal
yield reached 120.01mg/L. The production of CoQ10 was
proportional to cell growth, and the ﬁnal biomass obtained
was31.09g/L.Also,theexponentialfeedingfed-batchculture
resulted in the highest speciﬁc CoQ10 content within the
cell biomass, reaching 3.860mg/g, superior to that of the
aforementioned two cultures.
4. Conclusion
This work demonstrates that the use of HHP could be a
promising approach for mutagenesis to a CoQ10 producer
A. tumefaciens strain. A mutant strain PK38 was obtained
by HHP treatment: the intracellular CoQ10 content of thisJournal of Biomedicine and Biotechnology 7
Table 5: Eﬀect of complex nitrogen sources on DCW and CoQ10 production by PK38 with batch culture.
CSP + (NH4)2SO4 (g/L) DCW (g/L) CoQ10 production (mg/L) Speciﬁc CoQ10 content (mg/g-DCW)
20+ 0 7.16 + 0.116d 17.65 + 0.098d 2.466 + 0.017c
20+ 5 6.73 + 0.139f 16.17 + 0.091f 2.403 + 0.010c
20+ 10 6.92 + 0.097e 17.08 + 0.082e 2.467 + 0.027c
20+ 15 7.13 + 0.067d 17.60 + 0.115d 2.469 + 0.031c
30+ 0 7.46 + 0.095c 18.92 + 0.146c 2.536 + 0.047b
30+ 5 7.65 + 0.107b 19.40 + 0.284b 2.537 + 0.068b
30+ 10 7.86 + 0.090a 20.62 + 0.121a 2.624 + 0.032a
30+ 15 7.60 + 0.512b 18.54 + 0.085c 2.439 + 0.162c
Data are shown as mean ± SD (n = 3). Means with the same letter are not signiﬁcantly diﬀerent as indicated by Duncan’s multiple range test (P < 0.05).
strain increased by 52.83% when compared to the wild-
type strain. Even though the mechanism of HHP-induced
mutagenesis is not clear, HHP treatment might aﬀect the
three enzymatic steps of CoQ10 biosynthesis. Sucrose was
the best carbon source, and CSP and ammonium sulfate
were the optimal nitrogen sources for CoQ10 production
withPK38.Fed-batchculturecouldsigniﬁcantlyimprovecell
growth and CoQ10 production. By the exponential feeding
strategy, the cell biomass and CoQ10 production increased
126.11 and 173.12%, much higher than those obtained in
the batch culture. There may be opportunities for further
enhancement of the CoQ10 production in this species.
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